曾淑玲TZENG,SHU-LING黃漢偉HUANG,HAN-WEIHUANG醫學研究所碩士班2026-10-292030-08-2720252025-07-23https://handle.ncl.edu.tw/11296/mpztxwhttps://scholars.csmu.edu.tw/handle/123456789/36756飲食影響身體健康,在面對大腸癌與胃癌,近年的研究發現吲哚化合物(Indole-3-carbinol, I3C)及其代謝轉換物 3,3'-二吲哚甲烷(3,3'diindolylmethane, DIM)作用在大腸癌與胃癌細胞株中會抑制其生長及誘發細胞死亡。在本篇研究中,便以 Hct15 及 DLD1 細胞株作為模型,探討DIM影響大腸癌細胞生長的分子路徑。 首先證實DIM處理 Hct15與DLD1細胞後,細胞生長有減緩的趨勢。接著觀察細胞凋亡相關蛋白表現,發現凋亡抑制蛋白XIAP,在DIM 處理後有表現下降。P53蛋白在Hct15 表現上升情況下觀察其下游目標P21蛋白,可以看到P21蛋白因為DIM的處理而表現下降。定量即時聚合酶連鎖反應結果卻表明兩細胞株中 P21 的 mRNA表現量會因為DIM的處理而表現上升。進一步利用報告基因分析螢光素酶測定 p21 的轉錄活性,更確定 p21 在基因轉錄的活性會因為DIM的處理而增加。隨後,利用蛋白酶體抑制劑MG132,發現DIM所誘導的 P21 表現下降並沒有因為蛋白酶體抑制劑的處理被恢復回來。 綜合上述,DIM的確增加了p21的轉錄活性,但卻抑制P21蛋白的表現,研究中也發現DIM使P21的表現下降並不是透過蛋白酶體ii 的降解,或許與轉譯過程有關,未來將會繼續朝此方向進行實驗。Diet plays a critical role in human health, particularly in relation to colorectal and gastric cancers. Recent studies have demonstrated that indole compounds, including indole-3-carbinol (I3C) and its major metabolite 3,3′-diindolylmethane (DIM), can suppress growth and induce cell death in colorectal and gastric cancer cell lines. In this study, Hct15 and DLD1 colorectal cancer cell lines were used as models to investigate the molecular pathways through which DIM influences tumor cell growth. Our results showed that DIM treatment attenuated the proliferation of both Hct15 and DLD1 cells. Examination of apoptosis-related proteins revealed that the expression of the anti-apoptotic protein XIAP decreased following DIM exposure. Interestingly, while p53 expression increased in Hct15 cells, its downstream effector P21 exhibited reduced protein levels upon DIM treatment. In contrast, quantitative real-time PCR analysis demonstrated that p21 mRNA expression was elevated in both cell lines after DIM treatment. Consistently, luciferase reporter assays further confirmed that DIM enhanced p21 transcriptional activity. However, treatment with the proteasome inhibitor MG132 failed to restore P21 protein levels suppressed by DIM. Taken together, these findings suggest that DIM enhances p21 transcriptional activity but paradoxically reduces P21 protein expression. Moreover, this downregulation does not appear to be mediated through proteasomal degradation, implying a potential involvement of translational regulation. Future studies will be directed toward elucidating the underlying mechanisms responsible for this discrepancy.大腸癌33'-二吲哚甲烷P21蛋白p21轉錄活性蛋白酶體抑制劑colorectal and gastric cancers3'-diindolylmethaneP21 proteintranscriptional activity of p21proteasome inhibitor3,3‘-Diindolylmethane 經由P21調控大腸癌細胞生長機制探討thesis